Novel Cell Therapy Using Mesenchymal Stromal Cell Sheets for Medication-Related Osteonecrosis of the Jaw

Despite medication-related osteonecrosis of the jaw (MRONJ) being first reported in 2003, the optimal treatment and prevention modalities for MRONJ are not clear. As a result, dentistry, oral surgery, and departments involved in the treatment of cancer and bone diseases are struggling with the manag...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaibuchi, Nobuyuki, Iwata, Takanori, Koga, Yoko Kawase, Okamoto, Toshihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Bioengineering and Biotechnology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133503/
https://www.ncbi.nlm.nih.gov/pubmed/35646846
http://dx.doi.org/10.3389/fbioe.2022.902349

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133503/
https://www.ncbi.nlm.nih.gov/pubmed/35646846
http://dx.doi.org/10.3389/fbioe.2022.902349

Ejemplares similares